Orthostatic Systolic Blood Pressure Elevation and Incident Atrial Fibrillation: Insights From the SPRINT Trial
The Journal of Clinical Hypertension · 2025
DOI: 10.1111/jch.70122 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift The Journal of Clinical Hypertension, 2025. Verfasst von Jue Wang und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University and National Clinical Research Center for Cardiovascular Diseases, Beij…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Blood Pressure, Hypertension. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Beijing Municipal Science and Technology Commission.
Abstract (Originalsprache)
Exaggerated orthostatic changes in systolic blood pressure (SBP) were associated with adverse cardiovascular events. We aim to assess the association between orthostatic SBP changes and incident atrial fibrillation (AF). We performed a post hoc analysis of SPRINT (Systolic Blood Pressure Intervention Trial). Orthostatic SBP changes were defined as standing SBP minus seated SBP. Patients were grouped into tertiles of orthostatic SBP changes. We used Cox proportional regression models to assess the association of orthostatic SBP changes with incident AF. Among 8455 participants included in this analysis, 327 incident AF cases occurred during follow‐up. After adjusting for age, female, race, smoking, alcohol use, history of cardiovascular disease, history of chronic kidney disease, and body mass index, an SBP increase ≥6 mmHg to standing was independently associated with a 43% higher risk of incident AF (HR: 1.43; 95% CI: 1.07–1.90; p = 0.014) compared to nonsignificant orthostatic SBP changes (>–4 to –4 to
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University and National Clinical Research Center for Cardiovascular Diseases, Beijing, China.
- Heart Health Research Center, Beijing, China.
- Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China.
ORCID-Profile: Jue Wang, Le Zhou, Chao Jiang
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Beijing Municipal Science and Technology Commission
- Beijing Municipal Education Commission
- Chinese Society of Cardiology's Foundation
Zitieren
APA
Wang, J., Lv, W., Wang, Z., Li, S., Wang, Z., Zhou, L., Wang, Y., Ren, L., Jiang, C., He, L., Xia, S., Kong, X., Zuo, S., Kong, Y., Guo, X., Liu, X., Li, S., Tang, R., Long, D., …, & Ma, C. (2025). Orthostatic Systolic Blood Pressure Elevation and Incident Atrial Fibrillation: Insights From the SPRINT Trial. The Journal of Clinical Hypertension. https://doi.org/10.1111/jch.70122
Vancouver
Wang J, Lv W, Wang Z, Li S, Wang Z, Zhou L, et al. Orthostatic Systolic Blood Pressure Elevation and Incident Atrial Fibrillation: Insights From the SPRINT Trial. The Journal of Clinical Hypertension. 2025. doi:10.1111/jch.70122
BibTeX
@article{Wang2025,
author = {Wang, Jue and Lv, Wenhe and Wang, Zhen and Li, Sitong and Wang, Zhixian and Zhou, Le and Wang, Yufeng and Ren, Lan and Jiang, Chao and He, Liu and Xia, Shijun and Kong, Xiangyi and Zuo, Song and Kong, Yu and Guo, Xueyuan and Liu, Xiaoxia and Li, Songnan and Tang, Ribo and Long, Deyong and Sang, Caihua and Zhou, Ning and Du, Xin and Dong, Jianzeng and Ma, Changsheng},
title = {Orthostatic Systolic Blood Pressure Elevation and Incident Atrial Fibrillation: Insights From the SPRINT Trial},
journal = {The Journal of Clinical Hypertension},
year = {2025},
doi = {10.1111/jch.70122}
}
EUVIMED